Entering text into the input field will update the search result below

dPCR And qPCR Market Development And Future Trends

May 05, 2021 9:38 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Major factors influencing the growth of the market.
  • Leading players & Growth Strategies.
  • Geographic Overview.

Market growth influenced due to following factors-

  • Rising incidences of infectious diseases (such as HIV, tuberculosis, and malaria) and genetic disorders.
  • Continuous technological advancements in PCR technologies and the commercialization of lab-on-chip devices and microfluidics-based portable instruments.
  • Increasing investments, funds, and grants for genomic research.
  • Increasing use of biomarker profiling for disease diagnostics.

Global market size-

According to research report the dPCR and qPCR market is projected to reach $6.3 billion by 2024, growing at a CAGR of 8.8%.

Leading Players & Growth Strategies -

The major players operating in the dPCR and qPCR market include Thermo Fisher Scientific, Inc. (US), Takara Bio, Inc. (Japan), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), Fluidigm Corporation (US), bioMérieux S.A. (France), Danaher Corporation (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Eppendorf AG (Germany), Promega Corporation (US), and Analytik Jena AG (Germany). 

An analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as product launches; partnerships and collaborations; acquisitions; and expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the dPCR and qPCR market.

Bio-Rad Laboratories (US) is one of the leading players in the field of disease diagnostics & laboratory products. The company has a noteworthy presence in the dPCR and qPCR industry and a wide geographic presence in major markets such as the US, Germany, Japan, China, India, and Brazil. Bio-Rad is involved in the development, manufacturing, and marketing of more than 5,000 reagents, apparatuses, and laboratory instruments (including qPCR and dPCR products).

For More Details, Download PDF Brochure

Geographic Overview -

North America accounted for the largest share of the dPCR and qPCR market, followed by Europe in 2019. The large share of the North American regional segment can be attributed to the increased adoption of innovative and novel genomic analysis products (including advanced qPCR and dPCR products), availability of R&D funding for genomic research (coupled with the robust research infrastructure in the region), expanding use of PCR techniques in clinical diagnostics & forensics, and early commercialization of qPCR/dPCR products compared to other regions.


Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.